Why do you focus on "Dysregulation" instead of just measuring SIRT1 expression?

Static expression data is insufficient, as aging involves dynamic feedback failure in networks like SIRT1/AMPK. Our service precisely quantifies your therapeutic target's capacity to recalibrate this fundamental network dysregulation, thus addressing the etiology of the pathology.

Can this service test targets for neurodegeneration or only metabolic disease?

Yes, these nutrient sensing pathways are conserved and crucial for neuronal viability. We utilize specific primary human cell lines to validate targets for neurodegeneration, establishing a clear link between GRN stability and endpoints such as mitochondrial function or protein aggregation.

Nutrient Sensing Dysregulation based Longevity Gene Regulatory Network (GRN) Validation Service

Creative Biolabs provides causal validation of therapeutic leads by integrating advanced systems biology and experimental modeling. We offer comprehensive services that profile your compound's effect on the fundamental nutrient sensing gene regulatory network (GRN) in human-relevant cell systems. Clients gain a quantitative network stability score, a precise mechanism of action (MoA) statement for IP protection, and de-risked research assets with confirmed ability to shift cellular status from dysregulated aging to pro-longevity homeostasis.

Targeting Nutrient Sensing Network Stability for Longevity GRN Validation

Aging is defined by the progressive dysregulation of the GRN, including the IIS/mTOR (anabolic) and AMPK/Sirtuin (catabolic) pathways. This failure results in the collapse of cellular homeostasis, promoting senescence and metabolic disease. We cite the pivotal work demonstrating that even direct supplementation with NAD+ precursors, such as Nicotinamide Riboside, fails to activate SIRT1 or improve mitochondrial function in healthy human muscle, underscoring that dysregulation, not mere substrate availability, is the therapeutic bottleneck. Our service addresses this by targeting the network's stability.

What We Can Offer

Causal Dynamic Modeling

We simulate your target's effect using ordinary differential equations (ODEs) to predict whether it drives the aging GRN from an unstable, senescent state to a robust, long-lived stable fixed point. This provides a predictive efficacy profile, drastically de-risking your investment.

Network Stability Score

You receive a quantifiable metric that measures your target's ability to restore homeostasis by successfully stabilizing the dysregulated IIS/mTOR and SIRT1/AMPK axes. This is a crucial, single-figure benchmark for comparing different lead compounds.

Mechanism of Action Elucidation

We provide deep mechanistic insight into how your compound rewires the GRN, clarifying its precise role in stabilizing cellular crosstalk and strengthening your intellectual property (IP) claims.

Phenotype Translation

We link molecular changes (transcriptomics, metabolomics) directly to measurable longevity phenotypes (e.g., enhanced autophagy flux, improved mitochondrial function, reduced senescence markers), proving functional relevance in human cell models.

How We Can Help

Why Choose Us?

Output Feature	Unique Advantage
Dynamic Systems Analysis	We don't just measure molecules; we model the feedback loops that define the aging process. By confirming your target restores stability to the SIRT1/AMPK crosstalk, we ensure you are targeting the core mechanism of pathology, not just a symptom.
High-Resolution Profiling	Our integration of single-cell RNA-Seq with metabolic assays (measuring NAD⁺/acetyl-CoA ratios) provides an unprecedented depth of analysis.
Targeted Dysregulation Model	Our assays are specifically designed to mimic age-related nutrient stress (e.g., chronic anabolic signaling), ensuring your target's efficacy is tested in the most clinically relevant context. This approach differentiates us from simpler assays run on unstressed cells, which have demonstrated a failure to predict in vivo human outcomes.

Output Feature

Unique Advantage

Dynamic Systems Analysis

We don't just measure molecules; we model the feedback loops that define the aging process. By confirming your target restores stability to the SIRT1/AMPK crosstalk, we ensure you are targeting the core mechanism of pathology, not just a symptom.

High-Resolution Profiling

Our integration of single-cell RNA-Seq with metabolic assays (measuring NAD⁺/acetyl-CoA ratios) provides an unprecedented depth of analysis.

Targeted Dysregulation Model

Our assays are specifically designed to mimic age-related nutrient stress (e.g., chronic anabolic signaling), ensuring your target's efficacy is tested in the most clinically relevant context. This approach differentiates us from simpler assays run on unstressed cells, which have demonstrated a failure to predict in vivo human outcomes.

Customer Reviews

FAQs

Related Services

Mitochondrial Dysfunction

Focused screening using OCR and ECAR assays to test compound efficacy on mitochondrial respiration in diverse human cell lines (e.g., primary muscle, liver, and immune cells).

Learn More →

Proteostasis Loss

Direct measurement of 20S and 26S proteasome activity and ubiquitin-chain dynamics, providing critical data on protein degradation efficiency, which is essential for proteostasis.